Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-28

Clinical Trial Update: Efficacy and Safety of EsoDuo® [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of EsoDuo for gastroesophageal reflux disease is currently recruiting; there are no efficacy or safety results reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EsoDuo

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Gastro Esophageal Reflux | Phase 4 | Status: RECRUITING